110 related articles for article (PubMed ID: 2662014)
1. A transcriptional repressor of c-myc.
Kakkis E; Riggs KJ; Gillespie W; Calame K
Nature; 1989 Jun; 339(6227):718-21. PubMed ID: 2662014
[TBL] [Abstract][Full Text] [Related]
2. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
3. Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc.
Kime L; Wright SC
Biochem J; 2003 Feb; 370(Pt 1):291-8. PubMed ID: 12418961
[TBL] [Abstract][Full Text] [Related]
4. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
5. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression.
Kihara-Negishi F; Yamamoto H; Suzuki M; Yamada T; Sakurai T; Tamura T; Oikawa T
Oncogene; 2001 Sep; 20(42):6039-47. PubMed ID: 11593411
[TBL] [Abstract][Full Text] [Related]
6. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
Yang W; Shen J; Wu M; Arsura M; FitzGerald M; Suldan Z; Kim DW; Hofmann CS; Pianetti S; Romieu-Mourez R; Freedman LP; Sonenshein GE
Oncogene; 2001 Mar; 20(14):1688-702. PubMed ID: 11313917
[TBL] [Abstract][Full Text] [Related]
7. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
8. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
[TBL] [Abstract][Full Text] [Related]
9. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.
Rao G; Alland L; Guida P; Schreiber-Agus N; Chen K; Chin L; Rochelle JM; Seldin MF; Skoultchi AI; DePinho RA
Oncogene; 1996 Mar; 12(5):1165-72. PubMed ID: 8649810
[TBL] [Abstract][Full Text] [Related]
10. C-myc-S mu rearrangement in a murine plasmacytoma without visible chromosomal translocations.
Ohno S; Migita S; Murakami S
Oncogene; 1989 Dec; 4(12):1513-7. PubMed ID: 2687771
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding.
McEwan IJ; Dahlman-Wright K; Ford J; Wright AP
Biochemistry; 1996 Jul; 35(29):9584-93. PubMed ID: 8755740
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells.
Wang Q; Zhang H; Kajino K; Greene MI
Oncogene; 1998 Oct; 17(15):1939-48. PubMed ID: 9788437
[TBL] [Abstract][Full Text] [Related]
13. The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters.
Gutsch DE; Marcu KB; Kenney SC
Cell Mol Biol (Noisy-le-grand); 1994 Sep; 40(6):747-60. PubMed ID: 7812182
[TBL] [Abstract][Full Text] [Related]
14. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells.
Ishida S; Shudo K; Takada S; Koike K
Cell Growth Differ; 1995 Mar; 6(3):229-37. PubMed ID: 7794791
[TBL] [Abstract][Full Text] [Related]
15. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II.
Bousset K; Oelgeschläger MH; Henriksson M; Schreek S; Burkhardt H; Litchfield DW; Lüscher-Firzlaff JM; Lüscher B
Cell Mol Biol Res; 1994; 40(5-6):501-11. PubMed ID: 7735324
[TBL] [Abstract][Full Text] [Related]
16. c-Myc does not require max for transcriptional activity in PC-12 cells.
Ribon V; Leff T; Saltiel AR
Mol Cell Neurosci; 1994 Jun; 5(3):277-82. PubMed ID: 8087425
[TBL] [Abstract][Full Text] [Related]
17. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
18. p120-v-Abl expression overcomes TGF-beta1 negative regulation of c-myc transcription but not cell growth.
Birchenall-Roberts MC; Kim SJ; Bertolette DC; Turley JM; Fu T; Bang OS; Kasper JJ; Yoo YD; Ruscetti FW
Oncogene; 1996 Oct; 13(7):1499-509. PubMed ID: 8875988
[TBL] [Abstract][Full Text] [Related]
19. Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein.
Stojanova A; Caro C; Jarjour RJ; Oster SK; Penn LZ; Germinario RJ
J Cell Biochem; 2004 May; 92(2):400-13. PubMed ID: 15108364
[TBL] [Abstract][Full Text] [Related]
20. A plasmacytoma-specific factor binds the c-myc promoter region.
Kakkis E; Calame K
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7031-5. PubMed ID: 3313385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
